|
2022
|
Invention
|
Formulations for vegf receptor fusion proteins.
The present invention relates to a liquid formul... |
|
|
Invention
|
Formulations for vegf receptor fusion proteins. The present invention relates to a liquid formula... |
|
2021
|
Invention
|
Super-enhancers for recombinant gene expression in cho cells. The present invention belongs to th... |
|
|
Invention
|
Dimaleate form of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanopheny... |
|
|
Invention
|
Stabilization of pharmaceutical compositions comprising polysorbate.
The present invention relat... |
|
|
Invention
|
Stabilization of pharmaceutical compositions comprising polysorbate. The present invention relate... |
|
2020
|
Invention
|
Solid pharmaceutical compositions of androgen receptor antagonists.
The present invention belong... |
|
2019
|
Invention
|
Crystalline phosphate salt of selective jak1 inhibitor upadacitinib. The invention relates to cry... |
|
|
Invention
|
Solvate of a selective jak1 inhibitor. The present invention relates to acetic acid solvates of u... |
|
2017
|
Invention
|
A novel synthetic pathway towards solithromycin and purification thereof. The present invention r... |
|
2016
|
Invention
|
Peg-based dendron and process for producing the same. It is provided a process for preparing biod... |
|
|
Invention
|
A synthetic pathway towards apremilast. The present invention relates to an asymmetric process fo... |
|
|
Invention
|
A novel synthetic pathway towards apremilast. The present invention relates to a process for prov... |
|
|
Invention
|
Processes for preparing dolutegravir and cabotegravir and analogues thereof. The present inventio... |
|
2015
|
Invention
|
Novel solvates of n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,... |
|
|
Invention
|
Predicting productivity in early cell line development. The present invention relates in general ... |
|
|
Invention
|
Predicting genetically stable recombinant protein production in early cell line development. The ... |
|
|
Invention
|
Spray-freeze drying of polyelectrolyte nanoparticles containing the protein drug.
The present in... |
|
|
Invention
|
Spray-freeze drying of polyelectrolyte nanoparticles containing the protein drug. The present inv... |
|
|
Invention
|
Coated particles and pharmaceutical dosage forms. The present invention relates to coated particl... |
|
|
Invention
|
Hydrates of dolutegravir sodium. The invention relates to novel hydrates of dolutegravir sodium a... |
|
|
Invention
|
Novel hydrates of dolutegravir sodium. The invention relates to novel hydrates of dolutegravir so... |
|
|
Invention
|
Processes for the preparation of beta-aminosulfone compounds. The present invention relates to pr... |
|
|
Invention
|
Processes for the preparation of β-aminosulfone compounds. The present invention relates to proce... |
|
|
Invention
|
Stereoselective synthesis of intermediates in the preparation of ß-c-arylglucosides. The inventio... |
|
|
Invention
|
Novel crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethy... |
|
|
Invention
|
Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate. The present... |
|
|
Invention
|
Solid pharmaceutical compositions of androgen receptor antagonists. The present invention belongs... |
|
|
Invention
|
Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof.... |
|
|
Invention
|
Synthesis of vortioxetine via (2-(piperazine-1 -yl)phenyl)aniline intermediates. The present inve... |
|
2014
|
Invention
|
Oxidative degradation products of atrovastatin calcium. The present invention relates to oxidativ... |
|
|
Invention
|
A process for preparing a composition of pegylated proteins. This invention is in the field of pr... |
|
|
Invention
|
Synthesis of vortioxetine via (2-(piperazine-1 -yl)phenvl)lithium intermediates. The present inve... |
|
|
Invention
|
Stabilized amorphous lorcaserin hydrochloride. The present invention providesstabilized amorphous... |
|
|
Invention
|
Polymer selection for preparation of nps with high protein loading. The present invention relates... |
|
|
Invention
|
Nanoformulation of g-csf for non-parenteral delivery. The present invention relates to novel prot... |
|
|
Invention
|
Erythropoietin conjugates having oral bioavailability. The present invention relates to erythropo... |
|
|
Invention
|
Erythropoietin compositions for oral administration. The present invention relates to composition... |
|
|
Invention
|
Cell culture medium and process for controlling α-amidation and/or c-terminal amino acid cleavage... |
|
|
Invention
|
1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form. The present inve... |
|
|
Invention
|
Crystalline hydrates of 1-(β-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]ben... |
|
|
Invention
|
Process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine. The present invent... |
|
2013
|
Invention
|
Enzymatic route for the preparation of chiral gamma-aryl-beta-aminobutyric acid derivatives.
The... |
|
|
Invention
|
Ticagrelor adducts with divalent metal salts. The present invention relates to amorphous adducts ... |
|
|
Invention
|
Synthetic route for the preparation of β-aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[... |
|
|
Invention
|
Reduction of formation of amidated amino acids in cell lines for protein expression. The present ... |
